Avantax Advisory Services Inc. cut its position in shares of Haleon plc (NYSE:HLN – Free Report) by 17.2% during the fourth ...
In a report released on March 20, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price ...
Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...
This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...
(Alliance News) - Wellnex Life Ltd on Friday started trading on the AIM market in London. The Melbourne-based consumer healthcare company was already listed on the Australian Securities Exchange in ...
Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...
Pharmaceutical Technology on MSN2d
Pfizer sells 7.3% stake in Haleon for $3.3bn
The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.
The Consumer Healthcare Products Association (CHPA) awarded its Ivan D. Combe Lifetime Achievement Award to longtime industry ...
Bank of America says this constitutes the sharpest rotation out of the US and into Europe on record. The second banker said ...
Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.
Pfizer will get about $3.3 billion from its final stake sale in Haleon, according to a Wednesday filing with the London Stock ...
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...